414 related articles for article (PubMed ID: 18327267)
1. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins.
Cirl C; Wieser A; Yadav M; Duerr S; Schubert S; Fischer H; Stappert D; Wantia N; Rodriguez N; Wagner H; Svanborg C; Miethke T
Nat Med; 2008 Apr; 14(4):399-406. PubMed ID: 18327267
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.
Yadav M; Zhang J; Fischer H; Huang W; Lutay N; Cirl C; Lum J; Miethke T; Svanborg C
PLoS Pathog; 2010 Sep; 6(9):e1001120. PubMed ID: 20886104
[TBL] [Abstract][Full Text] [Related]
3. Bacteria fight back against Toll-like receptors.
O'Neill LA
Nat Med; 2008 Apr; 14(4):370-2. PubMed ID: 18391934
[No Abstract] [Full Text] [Related]
4. Microbial Toll/interleukin 1 receptor proteins: a new class of virulence factors.
Cirl C; Miethke T
Int J Med Microbiol; 2010 Aug; 300(6):396-401. PubMed ID: 20451449
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.
Fischer H; Yamamoto M; Akira S; Beutler B; Svanborg C
Eur J Immunol; 2006 Feb; 36(2):267-77. PubMed ID: 16385628
[TBL] [Abstract][Full Text] [Related]
6. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
[TBL] [Abstract][Full Text] [Related]
8. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
[TBL] [Abstract][Full Text] [Related]
9. [Progress in TcpC research].
Pan JP; Xin XL
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):481-5. PubMed ID: 24167126
[TBL] [Abstract][Full Text] [Related]
10. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.
Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L
Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570
[TBL] [Abstract][Full Text] [Related]
12. TIRAP: an adapter molecule in the Toll signaling pathway.
Horng T; Barton GM; Medzhitov R
Nat Immunol; 2001 Sep; 2(9):835-41. PubMed ID: 11526399
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry.
Snyder GA; Deredge D; Waldhuber A; Fresquez T; Wilkins DZ; Smith PT; Durr S; Cirl C; Jiang J; Jennings W; Luchetti T; Snyder N; Sundberg EJ; Wintrode P; Miethke T; Xiao TS
J Biol Chem; 2014 Jan; 289(2):669-79. PubMed ID: 24275656
[TBL] [Abstract][Full Text] [Related]
14. The genome of the sponge Amphimedon queenslandica provides new perspectives into the origin of Toll-like and interleukin 1 receptor pathways.
Gauthier ME; Du Pasquier L; Degnan BM
Evol Dev; 2010; 12(5):519-33. PubMed ID: 20883219
[TBL] [Abstract][Full Text] [Related]
15. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli.
Snyder GA; Cirl C; Jiang J; Chen K; Waldhuber A; Smith P; Römmler F; Snyder N; Fresquez T; Dürr S; Tjandra N; Miethke T; Xiao TS
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6985-90. PubMed ID: 23569230
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of bacterial interference with TLR4 signaling by Brucella Toll/interleukin-1 receptor domain-containing protein TcpB.
Alaidarous M; Ve T; Casey LW; Valkov E; Ericsson DJ; Ullah MO; Schembri MA; Mansell A; Sweet MJ; Kobe B
J Biol Chem; 2014 Jan; 289(2):654-68. PubMed ID: 24265315
[TBL] [Abstract][Full Text] [Related]
18. To con protection: TIR-domain containing proteins (Tcp) and innate immune evasion.
Patterson NJ; Werling D
Vet Immunol Immunopathol; 2013 Sep; 155(3):147-54. PubMed ID: 23871438
[TBL] [Abstract][Full Text] [Related]
19. Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response.
Pasi S; Kant R; Surolia A
J Biol Chem; 2016 Jun; 291(23):12358-69. PubMed ID: 27022030
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and phylogenetic history of the TcpC virulence determinant in Escherichia coli.
Schubert S; Nörenberg D; Clermont O; Magistro G; Wieser A; Romann E; Hoffmann C; Weinert K; Denamur E
Int J Med Microbiol; 2010 Nov; 300(7):429-34. PubMed ID: 20547102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
